Efficacy and safety of full-dose dabrafenib and trametinib combination therapy in a patient on hemodialysis with metastatic melanoma

被引：1
|
作者：
Hayakawa, Kazuma [1 ]
Wakimoto, Hiroko [1 ]
Mae, Kenichihro [1 ]
Irisawa, Ryokichi [1 ]
Harada, Kazutoshi [1 ]
机构：
[1] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2021年 / 60卷 / 04期
关键词：
D O I：
10.1111/ijd.15298
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：516 / 517
页数：2
相关论文
共 50 条
  • [41] Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysis
    Elmes, Joseph B.
    Davis, Jessica M.
    Musselwhite, Laura W.
    Chiad, Zane
    Moore, Donald C.
    Amin, Asim
    MELANOMA RESEARCH, 2024, 34 (05) : 465 - 468
  • [42] Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report
    Niro, Alfredo
    Recchimurzo, Nicola
    Sborgia, Alessandra
    Guida, Michele
    Alessio, Giovanni
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (05) : 783 - 785
  • [43] Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma
    Cebollero, Ana
    Puertolas, Teresa
    Pajares, Isabel
    Calera, Lourdes
    Anton, Antonio
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (04) : 458 - 462
  • [44] Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma
    Takahashi, Akira
    Namikawa, Kenjiro
    Nakano, Eiji
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2020, 47 (03): : 257 - 264
  • [45] Dabrafenib and Trametinib Combination Therapy versus Docetaxel in Previously Treated Metastatic NSCLC: an Adjusted Indirect Comparison
    Sasane, M.
    Li, J.
    Zhang, P.
    Zhao, J.
    Ricculli, M. L.
    Signorovitch, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1555 - S1556
  • [46] BRAF-mutated, acral verrucous melanoma successfully treated by dabrafenib plus trametinib combination therapy
    Kiyohara, T.
    Nagano, N.
    Miyamoto, M.
    Shijimaya, T.
    Nakamaru, S.
    Makimura, K.
    Tanimura, H.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (08) : 945 - 946
  • [47] Comparative efficacy of dabrafenib plus trametinib versus treatment options for metastatic melanoma in first-line settings
    Wu, Jing
    Das, Jaydeep
    Kalra, Manik
    Ratto, Barbara
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (04) : 267 - 280
  • [48] Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib
    Winkler, J. K.
    Buder-Bakhaya, K.
    Ellert, E.
    Herpel, E.
    Martens, U. M.
    Enk, A.
    Hassel, J. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : E31 - E32
  • [49] VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report
    Gunaratnam, Cadric
    Muzicenco, Olga
    Sivagurunathan, Premala
    Franzco, Michael Hogden
    JOURNAL OF SURGICAL CASE REPORTS, 2024, 2024 (03):
  • [50] Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy
    Irimada, Moyuka
    Fujimura, Taku
    Kambayashi, Yumi
    Tsukada, Akira
    Takahashi, Toshiya
    Hashimoto, Akira
    Aiba, Setsuya
    JOURNAL OF DERMATOLOGY, 2019, 46 (07): : E256 - E258
12345